Lance Thibault
Director of Finance/CFO bei FINCH THERAPEUTICS GROUP, INC.
Profil
Lance E.
Thibault is currently the Managing Director-Accounting & Reporting Advisory at Danforth Advisors LLC since 2020.
He is also the Chief Financial Officer at Finch Therapeutics Group, Inc. since 2023.
Previously, Mr. Thibault worked as a Director at PricewaterhouseCoopers LLP (United Kingdom).
He also served as the Finance Director at Paratek Pharmaceuticals, Inc. Additionally, he held the position of Treasurer at deCODE genetics, Inc. from 2010 to 2010.
Mr. Thibault was the Chief Financial & Accounting Officer at Proteostasis Therapeutics, Inc. from 2016 to 2016.
He also served as the CFO, Secretary & Treasurer at Pieris Pharmaceuticals, Inc. from 2017 to 2018.
In 2022, he briefly held the position of Chief Financial & Accounting Officer at Arcellx, Inc. Mr. Thibault was the Chief Financial Officer at Aadi Subsidiary, Inc. and Aadi Bioscience, Inc. in 2021.
Mr. Thibault obtained his undergraduate degree from Bentley University in 1988.
Aktive Positionen von Lance Thibault
| Unternehmen | Position | Beginn |
|---|---|---|
| FINCH THERAPEUTICS GROUP, INC. | Director of Finance/CFO | 16.05.2023 |
Danforth Advisors LLC
 Danforth Advisors LLC Investment ManagersFinance Danforth Advisors LLC provides advisory services. It offers finance support and stratigic consultation services for life science firm. The company was founded by Gregg Beloff and Daniel Geffken and is headquartered in Southborough, MA. | Corporate Officer/Principal | 01.07.2020 |
Ehemalige bekannte Positionen von Lance Thibault
| Unternehmen | Position | Ende |
|---|---|---|
| ARCELLX, INC. | Director of Finance/CFO | 23.05.2022 |
| AADI BIOSCIENCE, INC. | Director of Finance/CFO | 28.11.2021 |
| PIERIS PHARMACEUTICALS, INC. | Director of Finance/CFO | 09.08.2017 |
| PROTEOSTASIS THERAPEUTICS, INC. | Director of Finance/CFO | 04.08.2016 |
deCODE genetics, Inc.
 deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology deCODE genetics, Inc. is a bio-pharmaceutical company. It developing and marketing products to improve the treatment, diagnosis and prevention of common diseases. deCODE applies its capabilities in chemistry and structural biology to the development of drugs in major therapeutic areas, and applies its discoveries in human genetics to bring to market DNA-based reference laboratory tests and consumer genome analysis services to assess individual risk of common diseases. The company was founded by Kari Stefansson and Jeffrey Gulcher in August 1996 and is headquartered in Reykjavík, Iceland. | Director of Finance/CFO | 21.05.2010 |
Ausbildung von Lance Thibault
| Bentley University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 5 |
|---|---|
| PARATEK PHARMACEUTICALS, INC. | Health Technology |
| PIERIS PHARMACEUTICALS, INC. | Health Technology |
| ARCELLX, INC. | Health Technology |
| FINCH THERAPEUTICS GROUP, INC. | Health Services |
| AADI BIOSCIENCE, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
deCODE genetics, Inc.
deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology deCODE genetics, Inc. is a bio-pharmaceutical company. It developing and marketing products to improve the treatment, diagnosis and prevention of common diseases. deCODE applies its capabilities in chemistry and structural biology to the development of drugs in major therapeutic areas, and applies its discoveries in human genetics to bring to market DNA-based reference laboratory tests and consumer genome analysis services to assess individual risk of common diseases. The company was founded by Kari Stefansson and Jeffrey Gulcher in August 1996 and is headquartered in Reykjavík, Iceland. | Health Technology |
PricewaterhouseCoopers LLP (United Kingdom)
 PricewaterhouseCoopers LLP (United Kingdom) Other Consumer ServicesConsumer Services PricewaterhouseCoopers LLP engages in the provision of accounting services. Its services include audit and assurance, accounting advisory, risk assurance, tax management, corporate insolvency, life cycle assessment, forensic services, private equity advisory, and financial reporting valuations. The company is headquartered in London, the United Kingdom. | Consumer Services |
Proteostasis Therapeutics, Inc.
 Proteostasis Therapeutics, Inc. BiotechnologyHealth Technology Proteostasis Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It engages in the discovery and development of novel therapeutics to treat cystic fibrosis (CF) and other diseases caused by an imbalance in the proteostasis network. The company was founded by William Balch, Jeffery W. Kelly, Andrew Dillin, Richard I. Morimoto, Alfred Lewis Goldberg, Daniel Finley, Christopher T. Walsh, and Randall W. King in 2006 and is headquartered in Boston, MA. | Health Technology |
Danforth Advisors LLC
Danforth Advisors LLC Investment ManagersFinance Danforth Advisors LLC provides advisory services. It offers finance support and stratigic consultation services for life science firm. The company was founded by Gregg Beloff and Daniel Geffken and is headquartered in Southborough, MA. | Finance |
Aadi Subsidiary, Inc.
 Aadi Subsidiary, Inc. BiotechnologyHealth Technology Aadi Subsidiary, Inc. engages in biopharmaceutical company. Its therapeutic programs include pulmonary arterial hypertension, pediatric solid tumors, solid tumors with mTOR activation and mitochondrial disease. The company was founded by Neil Desai and is headquartered in Pacific Palisades, CA. | Health Technology |
